Nabriva Therapeutics Forschungs GMBH
This article was originally published in Start Up
Executive Summary
In January, Sandoz spun out Nabriva Therapeutics to initiate clinical development of three classes of antibiotics. Using medicinal chemistry, Sandoz had created thousands of compounds derived from intermediates used in the manufacture of generic antibiotics, which were themselves active against bacteria.